Abstract 189 Table 1

Conversion efficacy, side effects of subcutaneous ICD

Research StudyConversion efficacyComplications
Bardy, et al., 2010 98% of induced VF, 100% of spontaneous VT 3.6% infection (2/55)
1.81% pocket revision (1/55)
Weiss R, et al., 103 100% 1%
EFFORTLESS trial, 2014 88%- first shock
100% - within 5 shocks
6%
El Chami, et al., 2015 - 0% in ESRD patients
Burke, et al., 2015 90.1% - First shock
98.2% - within 5 shocks
11.1%
PRAETORIAN trial, 2020 - Non inferior to transvenous ICD for composite outcome of complications and inappropriate shocks.